A detailed history of Quantinno Capital Management LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Quantinno Capital Management LP holds 81,620 shares of GILD stock, worth $7.67 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
81,620
Previous 32,710 149.53%
Holding current value
$7.67 Million
Previous $2.24 Million 204.86%
% of portfolio
0.09%
Previous 0.04%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$66.59 - $83.99 $3.26 Million - $4.11 Million
48,910 Added 149.53%
81,620 $6.84 Million
Q2 2024

Aug 14, 2024

SELL
$63.15 - $72.88 $2.15 Million - $2.49 Million
-34,121 Reduced 51.06%
32,710 $2.24 Million
Q1 2024

May 14, 2024

BUY
$71.58 - $87.29 $2.08 Million - $2.53 Million
28,999 Added 76.65%
66,831 $4.9 Million
Q4 2023

Feb 14, 2024

BUY
$73.27 - $83.09 $380,784 - $431,818
5,197 Added 15.92%
37,832 $3.06 Million
Q3 2023

Nov 14, 2023

SELL
$73.94 - $80.67 $792,193 - $864,298
-10,714 Reduced 24.72%
32,635 $2.45 Million
Q2 2023

Aug 04, 2023

BUY
$76.01 - $86.7 $832,233 - $949,278
10,949 Added 33.79%
43,349 $3.34 Million
Q1 2023

May 03, 2023

BUY
$77.31 - $88.08 $389,565 - $443,835
5,039 Added 18.42%
32,400 $2.69 Million
Q4 2022

Feb 13, 2023

BUY
$62.32 - $89.47 $643,765 - $924,225
10,330 Added 60.65%
27,361 $2.35 Million
Q3 2022

Nov 07, 2022

BUY
$59.54 - $68.01 $545,088 - $622,631
9,155 Added 116.24%
17,031 $1.05 Million
Q2 2022

Aug 15, 2022

BUY
$57.72 - $65.01 $454,602 - $512,018
7,876 New
7,876 $487,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Quantinno Capital Management LP Portfolio

Follow Quantinno Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantinno Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantinno Capital Management LP with notifications on news.